MedPath

海南天盛保和生物科技有限公司

Ownership
-
Established
2020-09-14
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution

Product Name
氨溴特罗口服溶液
Approval Number
国药准字H20249679
Approval Date
Dec 6, 2024
NMPA

Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution

Product Name
氨溴特罗口服溶液
Approval Number
国药准字H20249548
Approval Date
Dec 1, 2024
NMPA

Metaraminol Bitartrate Injection

Product Name
重酒石酸间羟胺注射液
Approval Number
国药准字H20243875
Approval Date
Jun 4, 2024
NMPA

Magnesium Sulfate Injection

Product Name
硫酸镁注射液
Approval Number
国药准字H20243251
Approval Date
Feb 23, 2024
NMPA

Magnesium Sulfate Injection

Product Name
硫酸镁注射液
Approval Number
国药准字H20243252
Approval Date
Feb 23, 2024
NMPA

Cetrorelix Acetate for Injection

Product Name
注射用醋酸西曲瑞克
Approval Number
国药准字H20233630
Approval Date
May 29, 2023
NMPA

Somatostatin for Injection

Product Name
注射用生长抑素
Approval Number
国药准字H20223138
Approval Date
Mar 16, 2022
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.